Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-055-3 | CAS number: 7784-25-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2002-09-18 to 2003-03-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to the OECD Guideline No. 423 and in compliance with the GLP, information on the test substance available.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Aluminium ammonium bis(sulphate)
- EC Number:
- 232-055-3
- EC Name:
- Aluminium ammonium bis(sulphate)
- Cas Number:
- 7784-25-0
- Molecular formula:
- Al.H3N.2H2O4S
- IUPAC Name:
- aluminium ammonium bis(sulphate)
- Details on test material:
- - Name of test material (as cited in study report): Curb Powder, Aluminium ammonium sulfate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Breeding Facility, jai Research Foundation, India
- Age at study initiation: 10 weeks old at the time of dosing
- Weight at study initiation: 188 to 202 g
- Fasting period before study: No data
- Housing: 3 animals per cage in polypropylene cages covered with stainless steel grid top. Autoclaved clean rice husk was used as the bedding material.
- Diet (e.g. ad libitum): ad libitum; rat pellet diet (Amrut brand) manufactured by Pranav Agro Industries Limited, Pune, Mahashtra, India
- Water (e.g. ad libitum): ad libitum in a polypropylene water bottle with a stainless steel nozzle. The drinking water was filtered through Aquagard water filter system.
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 to 25 °C
- Humidity (%): 67%
- Air changes (per hr): 18 air changes per hour
- Photoperiod (hrs dark / hrs light): 12h artificial light / 12 h darkness
IN-LIFE DATES: No data
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- distilled
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: no data
- Amount of vehicle (if gavage): a dose volume of 10mL/kg bw was calculated for each rat
- Justification for choice of vehicle: no data
- Lot/batch no. (if required): not required
- Purity: no data, distilled water
MAXIMUM DOSE VOLUME APPLIED: no data
DOSAGE PREPARATION (if unusual): not required
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 6 female
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Deaths and overt signs of toxicity were recorded at 30 minutes, 1, 2, 3, 4 hours and once thereafter oral intubation on the day of dosing. Then, the animals were observed twice per day for the duration of the observation period. The animals were weighing prior the treatment (day 0) and on days 7 and 14 after the administration of the test substance.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight. At the end of 14 day observation period, a gross pathological examination was performed for all animals, consisting of an external examination and opening of abdominal and thoracic cavities. - Statistics:
- No data
Results and discussion
- Preliminary study:
- No data
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At the dose level of 2000 mg Aluminium ammonium sulfate / kg bw, no mortality was observed.
- Clinical signs:
- other: All animals were found normal after dosing and during the observation period.
- Gross pathology:
- External examination of the animals did not reveal any abnormality or lesion of pathological significance
Internal examination revealed lesions in lungs (consolidation / hepatisation) and uterus (hydrometra).
Above recorded lesions were spontaneous / incidental in nature and unrelated with test subtance administration. - Other findings:
- No additional data
Any other information on results incl. tables
Table 7.2.1/2: Mean Body Weights
Dose (mg / kg bw) |
Sex |
Number of Animals |
Mean Body Weights (g) |
Mean Per cent Body Weight Change |
|||
0 day |
7 days |
14 days |
7 days |
14 days |
|||
2000 |
Female |
3 |
192±6 |
222± 6 |
238± 16 |
15.4± 0.4 |
23.6± 8.1 |
3 |
196± 6 |
220± 20 |
233± 27 |
12.1± 27 |
18.9± 11.4 |
Values are mean± standard deviation
Table 7.2.1/3: External and Internal Examinations
Rat n° |
External examination |
Internal examination |
1 |
NAD |
Lungs : Partial hepatisation Uterus : Bilateral hydrometra (+) |
2 |
NAD |
|
3 |
NAD |
|
4 |
Uterus : Hydrometra (+) |
|
5 |
NAD |
|
6 |
Lungs : Consolidation (++) |
NAD: No Abnormalities Detected
(+): Mild
(++): Moderate
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the test conditions, aluminium ammonium sulfate is not classified according to the criteria of the Annex VI to the CLP Regulation and to the 67/548/EEC Directive.
- Executive summary:
In an acute toxic class method study, Aluminium ammonium sulfate was administered by gavage to 6 female Wistar rats at a single dose of 2000 mg/kg bw. This study was performed in compliance with Good Laboratory Practices and according to OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method).
Deaths and overt signs of toxicity were recorded at 30 minutes, 1, 2, 3, 4 hours and once thereafter oral intubation on the day of dosing. Then, the animals were observed twice per day for the duration of the observation period. The animals were weighing prior the treatment (day 0) and on days 7 and 14 after the administration of the test substance.
At the end of 14 day observation period, a gross pathological examination was performed for all animals, consisting of an external examination and opening of abdominal and thoracic cavities.
At the dose level of 2000 mg Aluminium ammonium sulfate / kg bw, all animals were found normal after dosing and during the observation period. There was a normal increase in the body weight of all treated animals and no mortality was observed. The gross pathological examination revealed no anormality due to the test substance.
Therefore, the acute oral lethal dose (LD50) of Aluminium ammonium sulfate is > 2000 mg / kg bw .
Under the test conditions, aluminium ammonium sulfate is not classified according to the criteria of the Annex VI to the Regulation N° 1272/2008 and to the 67/548/EC Directive.
This study is considered as acceptable and satisfies the requirement for acute oral toxicity endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
